Up-regulated expressions of IL-37 in serum have been reported in many inflammation-related disorders, such as systemic lupus erthymatosus (SLE) [16], rheumatoid arthritis (RA) [17] and acute coronary syndrome [23]. Here, IL37 is linked to systemic lupus erythematosus.